全球Breast Cancer Therapy Marketis anticipated to reach USD 29.6 Billion by 2026 according to a new research published by Polaris Market Research. In 2017, the targeted therapy segment dominated the global market, in terms of revenue.
Breast cancer is a disorder which is observed as malignant cell growth in the breast area. Such cancer can start at the breast tissue, ducts, or the lobules. In general, cancers developing from lobules are known as lobular carcinomas while cancer developing from the ducts are known as ductal carcinomas. The symptoms of cancer include dimpling of the skin, lumps, alteration in the breast size and impeding of fluid coming from breast. Generally, breast cancer is observed as the common disease in women over the age of 50. Moreover, the breast cancer is second most common disorder among all cancer types. This disease can be diagnosed and controlled by imaging test, physical tests, biopsy and appropriate care.
全球乳腺癌therapies market is majorly driven by increasing occurrence of breast cancer cases across the globe. Rising number of breast cancer cases are related with early menarche, protracted exposure to endogenous estrogens, late menopause and late stage at first childbirth which all are anticipated to render high impact on the market growth. In addition, launch of several screening and diagnostic programs and increasing advancement in technology are other factors expected to make a remarkable growth in the market. Moreover, increasing occurrence of obesity in women after menopause, increasing consciousness regarding breast cancer, and lifestyle risk factors (alcohol consumption and smoking) are other circumstances expected to drive the growth in global breast cancer therapies market.
有问题吗？在通过单击下面的链接，请在购买此报告之前请求示例或进行查询：
//m.nkkjrh.com/industry-analysis/breast-cancer-therapy-market
地理上，北美占2017年全球乳腺癌疗法市场中最大的份额。主要是通过私营和公共组织的研发资金增加，随着该地区的乳腺癌患病率越来越多。此外，在美国大大增加的老年群体中，早期母乳喂养终止是刺激乳腺癌发展危险因素的因素，这反过来有望支持北美地区乳腺癌疗法市场的增长。由于随着生活方式变化的增加和健康风险的增加，亚太乳腺癌疗法市场预计在预测期内的预测期间将以重大速度增长。此外，提高了技术的采用，炼油经济环境和对疾病预防的崛起的认识是促进亚太地区乳腺癌疗效市场增长的其他因素。
The leading companies profiled in the Breast Cancer Therapies Market report include AstraZeneca, Bayer AG, Danaher, Bristol Myers Squibb, Eisai Co., Ltd., Merck & Co., Novartis AG, Novocure, Pfizer Inc., and F. Hoffmann-La Roche AG.